Patents by Inventor Peter C. Simpson

Peter C. Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11064917
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: July 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Patent number: 11058329
    Abstract: Sensor systems can be used to measure an analyte concentration. Sensor systems can include a base having a distal side configured to face towards a person's skin. An adhesive can couple the base to the skin. A transcutaneous analyte measurement sensor can be coupled to the base and can be located at least partially in the host. A transmitter can be coupled to the base and can transmit analyte measurement data to a remote device.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: July 13, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Minglian Shi, Sebastian Bohm, Maria Noel Brown Wells, John Patrick Majewski, Leah Morta Edra, Disha B. Sheth, John Michael Gray, Shanger Wang, Ted Tang Lee, Michael L. Moore, Jason Mitchell, Jennifer Blackwell, Neel Narayan Shah, Todd Andrew Newhouse, Jason Halac, Ryan Everett Schoonmaker, Paul V. Neale, Jiong Zou, Sean T. Saint
  • Patent number: 11051731
    Abstract: Systems and methods are disclosed which provide for a “factory-calibrated” sensor. In doing so, the systems and methods include predictive prospective modeling of sensor behavior, and also include predictive modeling of physiology. With these two correction factors, a consistent determination of sensitivity can be achieved, thus achieving factory calibration.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: July 6, 2021
    Assignee: DexCom, Inc.
    Inventors: Rui Ma, Naresh C. Bhavaraju, Thomas Stuart Hamilton, Jonathan Hughes, Jeff Jackson, David I-Chun Lee, Peter C. Simpson, Stephen J. Vanslyke
  • Publication number: 20210196162
    Abstract: Systems for applying a transcutaneous monitor to a person can include a telescoping assembly, a sensor, and a base with adhesive to couple the sensor to skin. The sensor can be located within the telescoping assembly while the base protrudes from a distal end of the system. The system can be configured to couple the sensor to the base by compressing the telescoping assembly.
    Type: Application
    Filed: January 5, 2021
    Publication date: July 1, 2021
    Inventors: Jason Halac, John Michael Gray, Neal Davis Johnston, Justen Deering England, Peter C. Simpson, Paul V. Neale, Jennifer Blackwell, Maria Noel Brown Wells, Kenneth Pirondini, Andrew Michael Reinhardt, Mark Douglas Kempkey
  • Publication number: 20210196163
    Abstract: Systems for applying a transcutaneous monitor to a person can include a telescoping assembly, a sensor, and a base with adhesive to couple the sensor to skin. The sensor can be located within the telescoping assembly while the base protrudes from a distal end of the system. The system can be configured to couple the sensor to the base by compressing the telescoping assembly.
    Type: Application
    Filed: March 12, 2021
    Publication date: July 1, 2021
    Inventors: Jason Halac, John Michael Gray, Neal Davis Johnston, Justen Deering England, Peter C. Simpson, Paul V. Neale, Jennifer Blackwell, Maria Noel Brown Wells, Kenneth Pirondini, Andrew Michael Reinhardt, Mark Douglas Kempkey
  • Publication number: 20210196206
    Abstract: Certain aspects of the present disclosure relate generally to a method for identifying a risk of sepsis in a body of a patient. The method includes measuring lactate concentrations associated with the body over one or more time periods. The method further includes identifying the risk of sepsis based on the lactate concentrations.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 1, 2021
    Inventors: Devon M. Headen, Peter C. Simpson, Matthew Lawrence Johnson
  • Patent number: 11045120
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 29, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
  • Publication number: 20210194542
    Abstract: Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are disclosed. In an embodiment, a method for transmitting data between a first communication device associated with an analyte sensor and a second communication device configured to provide user access to sensor-related information comprises: activating a transceiver of a first communication device associated with an analyte sensor at a first time; and establishing a two-way communication channel with the second communication device; wherein the activating comprises waking the transceiver from a low power sleep mode using a forced wakeup from the second communication device.
    Type: Application
    Filed: March 3, 2021
    Publication date: June 24, 2021
    Inventors: Thomas Miller, Mark Dervaes, Phong Lieu, Peter C. Simpson, Shawn Larvenz, Jacob S. Leach, Sebastian Bohm
  • Publication number: 20210186383
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 24, 2021
    Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Publication number: 20210186385
    Abstract: Methods and apparatus are provided for communication among display devices and sensor electronics unit in an analyte monitoring system. The analyte monitoring system may include a sensor that is configured to perform measurements indicative of analyte levels. The sensor may be communicatively coupled to the sensor electronics unit. The sensor electronics unit may be configured to transmit data indicative of analyte levels to the display devices using one or more communication protocols. Furthermore, the sensor electronics unit may be configured to operate in multiple modes, and switch between the modes in response to commands received from the display devices. Related systems, methods, and articles of manufacture are also described.
    Type: Application
    Filed: March 8, 2021
    Publication date: June 24, 2021
    Inventors: Jeffrey R. Wedekind, Douglas William Burnette, Aditya Mandapaka, Zebediah L. McDaniel, Peter C. Simpson, Arturo Garcia
  • Patent number: 11026605
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 8, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
  • Publication number: 20210161434
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 3, 2021
    Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Patent number: 11020031
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: June 1, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Publication number: 20210145330
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 20, 2021
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Publication number: 20210145331
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 20, 2021
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Publication number: 20210145329
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 20, 2021
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Publication number: 20210137429
    Abstract: Methods and apparatus are provided for communication among display devices and sensor electronics unit in an analyte monitoring system. The analyte monitoring system may include a sensor that is configured to perform measurements indicative of analyte levels. The sensor may be communicatively coupled to the sensor electronics unit. The sensor electronics unit may be configured to transmit data indicative of analyte levels to the display devices using one or more communication protocols. Furthermore, the sensor electronics unit may be configured to operate in multiple modes, and switch between the modes in response to commands received from the display devices. Related systems, methods, and articles of manufacture are also described.
    Type: Application
    Filed: January 19, 2021
    Publication date: May 13, 2021
    Inventors: Jeffrey R. Wedekind, Douglas William Burnette, Aditya Mandapaka, Zebediah L. McDaniel, Peter C. Simpson, Arturo Garcia
  • Publication number: 20210142912
    Abstract: Systems and methods disclosed provide ways for Health Care Professionals (HCPs) to be involved in initial patient system set up so that the data received is truly transformative, such that the patient not just understands what all the various numbers mean but also how the data can be used. For example, in one implementation, a CGM device is configured for use by a HCP, and includes a housing and a circuit configured to receive a signal from a transmitter coupled to an indwelling glucose sensor. A calibration module converts the received signal into clinical units. A user interface is provided that is configured to display a measured glucose concentration in the clinical units. The user interface is further configured to receive input data about a patient level, where the input data about the patient level causes the device to operate in a mode appropriate to the patient level.
    Type: Application
    Filed: January 7, 2021
    Publication date: May 13, 2021
    Inventors: Scott M. Belliveau, Naresh C. Bhavaraju, Darin Edward Chum Dew, Eric Cohen, Anna Leigh Davis, Mark Dervaes, Laura J. Dunn, Minda McDorman Grucela, Hari Hampapuram, Matthew Lawrence Johnson, Apurv Ullas Kamath, Steven David King, Katherine Yerre Koehler, Aditya Sagar Mandapaka, Zebediah L. McDaniel, Sumitaka Mikami, Subrai Girish Pai, Philip Mansiel Pellouchoud, Stephen Alan Reichert, Eli Reihman, Peter C. Simpson, Brian Christopher Smith, Stephen J. Vanslyke, Robert Patrick Van Tassel, Matthew D. Wightlin, Richard C. Yang, James Stephen Amidei, David Derenzy, Benjamin Elrod West, Vincent Crabtree, Michael Levozier Moore, Douglas William Burnette, Alexandra Elena Constantin, Nicholas Polytaridis, Dana Charles Cambra, Abhishek Sharma, Kho Braun, Patrick Wile McBride
  • Patent number: 11000215
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 11, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Patent number: 10993642
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: May 4, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin